Nifty

:

21995.85

Sensex

:

72488.99

-152.05 (-0.69%)
-454.69 (-0.62%)

Login

Nifty
Sensex

:
:

21995.85
72488.99

-152.05 (-0.69%)
-454.69 (-0.62%)

Mangalam Drugs And Organics Ltd.

Pharmaceuticals & Drugs

Rating :

37/99

BSE: 532637 | NSE: MANGALAM

Watchlist

NSE BSE

99.15

18-Apr-2024

Open
High
Low
Previous Close

101.00
102.35
98.55
99.95

Volume
Traded Value (lacs)
52 Week High
52 Week Low

31399
31.52
132.45
90.80

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

157.48
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

227.45
N/A
1.13

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.75
10.34
-1.09

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.26
21.40
-15.15

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-64.32

P:E (Median)

8 Years
5 Years
3 Years

10.56
8.39
11.42

P:BV (Average)

8 Years
5 Years
3 Years

1.38
1.38
1.37

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.06
10.55
11.89

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 97.34 63.33 53.70% 81.56 108.33 -24.71% 87.47 109.50 -20.12% 91.11 120.96 -24.68%
Expenses 90.36 56.86 58.92% 79.36 99.89 -20.55% 90.94 99.12 -8.25% 90.86 110.76 -17.97%
EBITDA 6.98 6.47 7.88% 2.19 8.43 -74.02% -3.47 10.38 - 0.24 10.20 -97.65%
EBIDTM 7.17% 10.22% 2.69% 7.78% -3.97% 9.48% 0.27% 8.43%
Other Income 0.00 0.14 -100.00% 0.03 0.00 0 0.02 0.01 100.00% 0.29 0.00 0
Interest 3.31 3.22 2.80% 3.25 2.56 26.95% 3.41 3.55 -3.94% 3.43 2.53 35.57%
Depreciation 3.62 2.88 25.69% 3.73 2.76 35.14% 3.42 2.60 31.54% 2.75 2.69 2.23%
PBT 0.04 0.50 -92.00% -4.75 3.12 - -10.29 4.24 - -5.65 4.98 -
Tax -0.46 0.08 - -1.19 0.90 - -0.75 1.23 - -1.26 -1.71 -
PAT 0.50 0.43 16.28% -3.56 2.23 - -9.54 3.00 - -4.39 6.69 -
PATM 0.51% 0.67% -4.36% 2.06% -10.90% 2.74% -4.81% 5.53%
EPS 0.32 0.27 18.52% -2.25 1.41 - -6.03 1.90 - -2.78 4.23 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 97.34 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 90.36 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 6.98 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 7.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 3.31 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 3.63 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.04 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax -0.46 0.00 - 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.50 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.51% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.31 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 357.48 372.25 451.07 384.70 282.35 227.58 279.38 302.89 295.02 220.58 122.52 Net Sales Growth -11.10% -17.47% 17.25% 36.25% 24.07% -18.54% -7.76% 2.67% 33.75% 80.04% Cost Of Goods Sold 256.79 250.64 306.64 251.96 195.35 153.61 166.76 195.93 203.92 157.25 78.10 Gross Profit 100.69 121.61 144.43 132.74 87.01 73.97 112.61 106.95 91.10 63.33 44.42 GP Margin 28.17% 32.67% 32.02% 34.50% 30.82% 32.50% 40.31% 35.31% 30.88% 28.71% 36.26% Total Expenditure 351.52 346.73 402.01 326.68 258.66 217.90 232.53 256.97 257.50 200.23 112.91 Power & Fuel Cost - 25.59 22.90 16.12 14.24 14.56 14.31 11.53 10.90 11.90 10.88 % Of Sales - 6.87% 5.08% 4.19% 5.04% 6.40% 5.12% 3.81% 3.69% 5.39% 8.88% Employee Cost - 34.61 37.25 29.88 26.04 25.82 22.98 19.08 14.39 10.91 10.25 % Of Sales - 9.30% 8.26% 7.77% 9.22% 11.35% 8.23% 6.30% 4.88% 4.95% 8.37% Manufacturing Exp. - 19.59 19.08 14.05 9.77 12.04 14.84 11.49 11.48 9.07 7.07 % Of Sales - 5.26% 4.23% 3.65% 3.46% 5.29% 5.31% 3.79% 3.89% 4.11% 5.77% General & Admin Exp. - 7.89 6.10 6.05 6.67 7.59 7.54 6.36 4.55 2.51 1.90 % Of Sales - 2.12% 1.35% 1.57% 2.36% 3.34% 2.70% 2.10% 1.54% 1.14% 1.55% Selling & Distn. Exp. - 6.84 7.82 7.61 5.16 3.96 5.58 9.21 9.83 8.14 4.62 % Of Sales - 1.84% 1.73% 1.98% 1.83% 1.74% 2.00% 3.04% 3.33% 3.69% 3.77% Miscellaneous Exp. - 1.57 2.22 1.01 1.42 0.32 0.51 3.36 2.43 0.45 4.62 % Of Sales - 0.42% 0.49% 0.26% 0.50% 0.14% 0.18% 1.11% 0.82% 0.20% 0.09% EBITDA 5.94 25.52 49.06 58.02 23.69 9.68 46.85 45.92 37.52 20.35 9.61 EBITDA Margin 1.66% 6.86% 10.88% 15.08% 8.39% 4.25% 16.77% 15.16% 12.72% 9.23% 7.84% Other Income 0.34 0.44 0.09 0.00 1.18 0.32 0.84 0.31 0.20 0.09 0.24 Interest 13.40 12.75 11.16 9.33 10.40 8.65 11.78 10.04 9.29 10.28 9.74 Depreciation 13.52 10.99 10.25 9.18 8.22 7.09 6.57 5.01 4.41 4.15 4.01 PBT -20.65 2.21 27.73 39.52 6.25 -5.74 29.35 31.18 24.02 6.01 -3.91 Tax -3.66 0.94 8.08 11.55 -2.00 2.29 9.46 8.91 7.98 -0.13 -0.87 Tax Rate 17.72% 42.53% 29.14% 29.23% -32.00% -39.90% 32.23% 28.58% 33.22% -2.16% 22.25% PAT -16.99 1.27 19.66 27.97 8.25 -8.03 19.89 22.27 16.03 6.14 -3.04 PAT before Minority Interest -16.99 1.27 19.66 27.97 8.25 -8.03 19.89 22.27 16.03 6.14 -3.04 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -4.75% 0.34% 4.36% 7.27% 2.92% -3.53% 7.12% 7.35% 5.43% 2.78% -2.48% PAT Growth -237.57% -93.54% -29.71% 239.03% - - -10.69% 38.93% 161.07% - EPS -10.75 0.80 12.44 17.70 5.22 -5.08 12.59 14.09 10.15 3.89 -1.92

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 151.96 150.56 130.79 103.94 95.66 103.77 85.72 61.52 29.36 23.22 Share Capital 15.83 15.83 15.83 15.83 15.83 15.83 15.83 14.38 13.18 13.18 Total Reserves 136.13 134.73 114.96 88.11 79.83 87.94 69.89 38.66 16.19 10.04 Non-Current Liabilities 42.32 47.75 24.25 17.26 24.88 23.18 26.03 25.37 41.10 40.79 Secured Loans 18.77 24.85 6.63 3.91 8.10 10.65 16.85 12.20 18.30 24.71 Unsecured Loans 0.00 0.25 0.25 0.26 0.50 0.50 0.00 4.72 21.10 15.49 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 165.36 130.11 109.08 109.47 90.81 99.84 77.76 72.87 99.43 61.43 Trade Payables 97.07 54.55 43.39 56.59 32.41 37.63 20.78 20.68 54.77 20.87 Other Current Liabilities 17.00 25.20 14.10 10.19 7.30 10.76 14.97 16.82 12.83 9.20 Short Term Borrowings 49.57 47.10 51.18 41.86 50.51 50.75 41.32 35.38 31.82 31.37 Short Term Provisions 1.72 3.27 0.40 0.83 0.59 0.71 0.70 0.00 0.00 0.00 Total Liabilities 359.64 328.42 264.12 230.67 211.35 226.79 189.51 159.76 169.89 125.44 Net Block 142.36 134.96 117.82 101.07 103.49 101.91 92.56 54.19 52.95 53.38 Gross Block 241.40 223.81 196.70 170.92 165.15 156.14 140.26 97.57 91.82 88.28 Accumulated Depreciation 99.04 88.85 78.88 69.85 61.66 54.23 47.70 43.38 38.88 34.89 Non Current Assets 153.04 143.39 130.19 111.49 106.32 103.95 93.72 60.11 53.86 54.03 Capital Work in Progress 9.49 5.71 6.35 1.24 0.20 0.07 0.00 4.93 0.00 0.00 Non Current Investment 0.00 0.00 0.22 0.22 0.24 0.24 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.19 2.72 5.79 8.96 2.38 1.73 1.16 0.99 0.91 0.65 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 206.58 185.03 133.92 119.17 105.04 122.84 95.78 99.65 116.04 71.42 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 1.64 0.24 0.24 0.18 Inventories 137.47 117.11 58.59 64.84 73.45 60.13 37.25 47.34 57.34 36.48 Sundry Debtors 46.53 46.49 54.31 39.98 17.63 45.21 36.82 30.14 44.25 29.69 Cash & Bank 2.69 1.95 0.59 1.63 1.43 0.43 0.63 0.50 0.68 0.10 Other Current Assets 19.90 3.79 3.66 2.48 12.53 17.07 19.45 21.43 13.53 4.97 Short Term Loans & Adv. 16.28 15.69 16.77 10.24 10.14 14.59 16.05 21.12 13.23 4.80 Net Current Assets 41.23 54.92 24.84 9.71 14.23 23.00 18.03 26.78 16.61 9.98 Total Assets 359.62 328.42 264.11 230.66 211.36 226.79 189.50 159.76 169.90 125.45

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 39.52 25.71 27.55 30.55 21.69 24.58 42.80 21.81 13.96 7.48 PBT 2.21 27.73 39.52 6.25 -5.74 29.35 31.18 24.02 6.01 -3.91 Adjustment 23.92 22.37 17.24 18.71 16.22 18.30 17.45 13.85 14.50 13.76 Changes in Working Capital 13.36 -15.59 -19.94 5.64 11.21 -16.81 1.50 -12.11 -6.48 -2.29 Cash after chg. in Working capital 39.50 34.52 36.82 30.60 21.69 30.83 50.13 25.76 14.03 7.57 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.03 -8.81 -9.27 -0.05 0.00 -6.26 -7.33 -3.95 -0.07 -0.08 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -22.17 -27.33 -31.29 -6.87 -9.26 -15.95 -39.45 -10.88 -3.84 -2.26 Net Fixed Assets -21.37 -26.47 -30.89 -6.81 -9.14 -15.95 -37.76 -10.68 -3.54 -2.15 Net Investments 0.00 0.22 0.00 0.02 0.00 1.40 -1.40 0.00 -0.06 0.00 Others -0.80 -1.08 -0.40 -0.08 -0.12 -1.40 -0.29 -0.20 -0.24 -0.11 Cash from Financing Activity -16.62 2.98 2.70 -23.48 -11.43 -8.82 -3.22 -11.11 -9.54 -5.21 Net Cash Inflow / Outflow 0.73 1.36 -1.04 0.20 1.00 -0.20 0.13 -0.18 0.58 0.01 Opening Cash & Equivalents 1.95 0.58 1.62 1.43 0.43 0.63 0.50 0.68 0.10 0.09 Closing Cash & Equivalent 2.68 1.95 0.58 1.63 1.43 0.43 0.63 0.50 0.68 0.10

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 96.00 95.12 82.63 65.67 60.44 65.56 54.15 36.89 22.28 17.62 ROA 0.37% 6.64% 11.31% 3.73% -3.67% 9.56% 12.76% 9.73% 4.16% -2.53% ROE 0.84% 13.97% 23.83% 8.27% -8.05% 20.99% 32.11% 38.91% 23.36% -12.28% ROCE 6.56% 18.34% 28.01% 10.66% 1.76% 25.35% 30.18% 29.14% 15.69% 5.86% Fixed Asset Turnover 1.60 2.15 2.09 1.86 1.61 2.08 2.63 3.20 2.50 1.46 Receivable days 45.61 40.78 44.73 33.58 44.31 48.65 39.11 44.78 59.90 76.86 Inventory Days 124.81 71.08 58.56 80.60 94.20 57.76 49.41 63.02 76.02 96.92 Payable days 110.40 58.29 72.42 66.80 55.04 44.26 30.96 51.61 68.98 50.57 Cash Conversion Cycle 60.01 53.58 30.86 47.38 83.47 62.15 57.56 56.19 66.94 123.21 Total Debt/Equity 0.49 0.52 0.49 0.48 0.66 0.66 0.77 1.13 2.65 3.32 Interest Cover 1.17 3.48 5.24 1.60 0.34 3.49 4.11 3.58 1.58 0.60

Top Investors:

ashutosh taparia

jyotiprasad taparia

ambika food industries private limited

Annual Reports:

News Update:

Mangalam Drugs&Org. - Quarterly Results
13th Feb 2024, 19:39 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback